141 related articles for article (PubMed ID: 9564473)
1. Correlation of in vitro fluconazole susceptibility with clinical outcome for severely ill patients with oropharyngeal candidiasis.
Arikan S; Akova M; Hayran M; Ozdemir O; Erman M; Gür D; Unal S
Clin Infect Dis; 1998 Apr; 26(4):903-8. PubMed ID: 9564473
[TBL] [Abstract][Full Text] [Related]
2. Correlation between in vitro resistance to fluconazole and clinical outcome of oropharyngeal candidiasis in HIV-infected patients.
Quereda C; Polanco AM; Giner C; Sánchez-Sousa A; Pereira E; Navas E; Fortún J; Guerrero A; Baquero F
Eur J Clin Microbiol Infect Dis; 1996 Jan; 15(1):30-7. PubMed ID: 8641300
[TBL] [Abstract][Full Text] [Related]
3. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
[TBL] [Abstract][Full Text] [Related]
4. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
Samaranayake YH; Samaranayake LP; Tsang PC; Wong KH; Yeung KW
J Oral Pathol Med; 2001 Jul; 30(6):336-46. PubMed ID: 11459319
[TBL] [Abstract][Full Text] [Related]
6. Mixed oropharyngeal candidiasis due to Candida albicans and non-albicans Candida strains in HIV-infected patients.
Dronda F; Alonso-Sanz M; Laguna F; Chaves F; Martínez-Suárez JV; Rodríguez-Tudela JL; González-López A; Valencia E
Eur J Clin Microbiol Infect Dis; 1996 Jun; 15(6):446-52. PubMed ID: 8839637
[TBL] [Abstract][Full Text] [Related]
7. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
Vazquez JA; Skiest DJ; Nieto L; Northland R; Sanne I; Gogate J; Greaves W; Isaacs R
Clin Infect Dis; 2006 Apr; 42(8):1179-86. PubMed ID: 16575739
[TBL] [Abstract][Full Text] [Related]
8. Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans.
Laguna F; Rodríguez-Tudela JL; Martínez-Súarez JV; Polo R; Valencia E; Díaz-Guerra TM; Dronda F; Pulido F
Clin Infect Dis; 1997 Feb; 24(2):124-30. PubMed ID: 9114134
[TBL] [Abstract][Full Text] [Related]
9. Point prevalence of oropharyngeal carriage of fluconazole-resistant Candida in human immunodeficiency virus-infected patients.
Martins MD; Lozano-Chiu M; Rex JH
Clin Infect Dis; 1997 Oct; 25(4):843-6. PubMed ID: 9356799
[TBL] [Abstract][Full Text] [Related]
10. The epidemiology of non-albicans Candida in oropharyngeal candidiasis in HIV patients.
Redding SW; Kirkpatrick WR; Dib O; Fothergill AW; Rinaldi MG; Patterson TF
Spec Care Dentist; 2000; 20(5):178-81. PubMed ID: 11203894
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of fluconazole in the treatment of upper gastrointestinal candidiasis in neutropenic patients with cancer: factors influencing the outcome.
Akova M; Akalin HE; Uzun O; Hayran M; Tekuzman G; Kansu E; Aslan S; Telatar H
Clin Infect Dis; 1994 Mar; 18(3):298-304. PubMed ID: 8011807
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patients.
Revankar SG; Dib OP; Kirkpatrick WR; McAtee RK; Fothergill AW; Rinaldi MG; Redding SW; Patterson TF
Clin Infect Dis; 1998 Apr; 26(4):960-3. PubMed ID: 9564483
[TBL] [Abstract][Full Text] [Related]
13. Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.
Walsh TJ; Gonzalez CE; Piscitelli S; Bacher JD; Peter J; Torres R; Shetti D; Katsov V; Kligys K; Lyman CA
J Clin Microbiol; 2000 Jun; 38(6):2369-73. PubMed ID: 10835005
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection.
Tumbarello M; Caldarola G; Tacconelli E; Morace G; Posteraro B; Cauda R; Ortona L
J Antimicrob Chemother; 1996 Oct; 38(4):691-9. PubMed ID: 8937963
[TBL] [Abstract][Full Text] [Related]
15. Low levels of antigenic variability in fluconazole-susceptible and -resistant Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
Lopez-Ribot JL; McAtee RK; Kirkpatrick WR; La Valle R; Patterson TF
Clin Diagn Lab Immunol; 1999 Sep; 6(5):665-70. PubMed ID: 10473514
[TBL] [Abstract][Full Text] [Related]
16. Oropharyngeal yeast flora and fluconazole resistance in HIV-infected patients receiving long-term continuous versus intermittent fluconazole therapy.
Heald AE; Cox GM; Schell WA; Bartlett JA; Perfect JR
AIDS; 1996 Mar; 10(3):263-8. PubMed ID: 8882665
[TBL] [Abstract][Full Text] [Related]
17. Correlation between antifungal susceptibility testing of Candida isolates from patients with HIV infection and clinical results after treatment with fluconazole.
Ruhnke M; Eigler A; Engelmann E; Geiseler B; Trautmann M
Infection; 1994; 22(2):132-6. PubMed ID: 8070927
[TBL] [Abstract][Full Text] [Related]
18. Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients.
Troillet N; Durussel C; Bille J; Glauser MP; Chave JP
Eur J Clin Microbiol Infect Dis; 1993 Dec; 12(12):911-5. PubMed ID: 8187785
[TBL] [Abstract][Full Text] [Related]
19. [Oropharyngeal candidiasis resistant to fluconazole in patients infected by HIV].
Drobacheff C; Manteaux A; Millon L; Reboux G; Barale T; Laurent R
Ann Dermatol Venereol; 1996; 123(2):85-9. PubMed ID: 8761757
[TBL] [Abstract][Full Text] [Related]
20. Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment.
Belazi M; Velegraki A; Koussidou-Eremondi T; Andreadis D; Hini S; Arsenis G; Eliopoulou C; Destouni E; Antoniades D
Oral Microbiol Immunol; 2004 Dec; 19(6):347-51. PubMed ID: 15491459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
